Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys

Psychopharmacology

Volumn 123, Issue 4, 1996, Pages 320-324

  Butelman, Eduardo R ^a   Negus, S Stevens ^a,c   Lewis, John W ^b   Woods, James H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Clocinnamox; Fentanyl; Irreversible antagonists; Operant behavior; Rhesus monkeys

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; CLOCINNAMOX; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; ETONITAZENE; FENTANYL; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; QUADAZOCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; FEMALE; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CINNAMATES; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MACACA MULATTA; MALE; MORPHINE DERIVATIVES; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; RECEPTORS, SIGMA; REINFORCEMENT SCHEDULE;

EID: 0029932330     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02246641     Document Type: Article

References (15)

1. Adams JU, Paronis CA, Holtzman SG (1990) Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine. J Pharmacol Exp Ther 255: 1027-1032
2. Burke T, Woods JH, Lewis JW, Medzihradsky F (1994) Irreversible opioid anatagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice. J Pharmacol Exp Ther 271: 715-721
3. Butelman ER, France CP, Woods JH (1995a) Agonist and antagonist effects of dynorphin A-(1-13) in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 275: 374-380
4. Butelman ER, Negus SS, Gatch MB, Chang KJ, Woods JH (1995b) BW373U86, a ∂-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys. Eur J Pharmacol 277: 285-287
5. Comer SD, Burke TF, Lewis JW, Woods JH (1992) Clocinnamox: a novel, systematically-active irreversible opioid antagonist. J Pharmacol Exp Ther 262: 1051-1056
6. France CP, Medzihradsky F, Woods JH (1994) Comparison of κ opioids in rhesus monkeys: behavioral effects and receptor binding affinities. J Pharmacol Exp Ther 268: 47-58
7. Mjanger E, Yaksh T (1991) Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists. J Pharmacol Exp Ther 258: 544-550
8. Negus SS, Burke TF, Medzihadsky F, Woods JH (1993) Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. J Pharmacol Exp Ther 267: 896-903
9. Negus SS, Butelman ER, Chang KJ, DeCosta BR, Winger G, Woods JH (1994) Behavioral effects of the systemically active-delta opioid anonist BW373U86 in rhesus monkeys. J Pharmacol Exp Ther 270: 1025-1034
10. Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16: 1-18
11. Walker EA, Butelman ER, DeCosta BR, Woods JH (1993) Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. J Pharmacol Exp Ther 267: 280-286
12. Walker EA, Zernig G, Woods JH (1995) Buprenorphine antagonism of mu opioids in the rhesus monkey tail withdrawal procedure. J Pharmacol Exp Ther 273: 1345-1352
13. Zernig G, Butelman ER, Lewis J, Woods JH (1994) In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox. J Pharmacol Exp Ther 269: 57-65
14. Zernig G, Burke T, Lewis JW, Woods JH (1995) Clocinnamox blocks only mu receptors irreversibly: binding evidence. Regul Pept (in press)
15. Zimmerman D, Leander DJ, Reel J, Hynes MD (1987) Use of beta-funaltrexamine to determine mu opioid receptor involve-ment in the analgesic activity of various opioid ligands. J Pharmacol Exp Ther 241: 374-378